CVS Health Corp. Hits New 52-Week High at $108.97

CVS Health Corp. has reached a significant milestone by hitting a new 52-week high of USD 108.97 on July 17, 2026. This achievement underscores the company's strong performance in the retailing sector, particularly as it has demonstrated a remarkable one-year performance of 78.28%, significantly outpacing the S&P 500's 18.43% return during the same period. With a market capitalization of USD 118,730 million, CVS Health Corp. is classified as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 13.00, indicating a favorable valuation compared to many peers in the industry. Additionally, the company offers a dividend yield of 2.83%, which may appeal to income-focused investors. CVS Health Corp. maintains a debt-to-equity ratio of 0.72, reflecting a balanced approach to leveraging, while its return on equity is reported at 12.13%. The price-to-book ratio of 1.58 further illustrates the company's solid financial standing. Overall, CVS Health Corp.'s recent performance highlights its robust position within the retailing industry.